Document is current
Any future updates will be listed below
-
Authors
Muller, Alissa
Sullivan, Jack
Schwarzer, Wibke https://orcid.org/0000-0001-7272-7645
Wang, Mantian
Park-Windhol, Cindy https://orcid.org/0000-0002-4881-4455
Hasler, Pascal W.
Janeschitz-Kriegl, Lucas
Duman, Mert https://orcid.org/0000-0003-4277-6272
Klingler, Beryll
Matsell, Jane https://orcid.org/0009-0000-3482-6255
Hostettler, Simon Manuel
Galliker, Patricia
Hou, Yanyan
Balmer, Pierre
Virág, Tamás
Barrera, Luis Alberto
Young, Lauren
Xu, Quan https://orcid.org/0000-0002-7659-1658
Magda, Dániel Péter https://orcid.org/0000-0003-3987-6520
Kilin, Ferenc
Khadka, Arogya
Moreau, Pierre-Henri
Fellmann, Lyne
Azoulay, Thierry
Quinodoz, Mathieu
Karademir, Duygu
Leppert, Juna
Fratzl, Alex https://orcid.org/0000-0003-4064-0742
Kosche, Georg
Sharma, Ruchi
Montford, Jair
Cattaneo, Marco https://orcid.org/0000-0002-6610-8431
Croyal, Mikaël
Cronin, Therese
Picelli, Simone https://orcid.org/0000-0002-1747-614X
Grison, Alice
Cowan, Cameron S.
Kusnyerik, Ákos https://orcid.org/0000-0001-9333-8104
Anders, Philipp https://orcid.org/0000-0003-1690-9043
Renner, Magdalena
Nagy, Zoltán Zsolt
Szabó, Arnold
Bharti, Kapil
Rivolta, Carlo https://orcid.org/0000-0002-0733-9950
Scholl, Hendrik P. N.
Bryson, David
Ciaramella, Giuseppe https://orcid.org/0000-0003-3339-7211
Roska, Botond https://orcid.org/0000-0002-9559-1450
György, Bence https://orcid.org/0000-0003-0766-6246
- License Information
-
More Information
Article History
Received: 11 May 2023
Accepted: 14 November 2024
First Online: 8 January 2025
Competing interests
: J.S., C.P-W., T.V., L.A.B., L.Y., A.K., D.B. and G.C. are employees and/or shareholders of Beam Therapeutics. Beam Therapeutics has filed a patent based on some of this work. H.P.N.S. is member of the Scientific Advisory Board of: Boehringer Ingelheim, Droia NV, Janssen Research & Development (Johnson & Johnson) and Okuvision and Tenpoint Therapeutics. H.P.N.S. is a member of the Data Monitoring and Safety Board/Committee of Belite Bio (DRAGON trial, ; LBS-008-CT02, ), F. Hoffmann-La Roche (VELODROME trial, ; DIAGRID trial, ; HUTONG trial) and ViGeneron (protocol no. VG901-2021-A) and a member of the Steering Committee of Novo Nordisk (FOCUS trial; ). B.R. is a consultant of SpliceBio. All other authors declare no competing interests.
